Consensus Group on New-Generation Antihistamines (CONGA): present status and recommendations.
Holgate
S T
ST
Respiratory Cell and Molecular Biology, Infection, Inflammation, and Repair Division, School of Medicine, University of Southampton, UK. sth@soton.ac.uk
Canonica
G W
GW
Simons
F E R
FE
Taglialatela
M
M
Tharp
M
M
Timmerman
H
H
Yanai
K
K
D000893:Anti-Inflammatory Agents / Q000276:immunology / Q000627:therapeutic use; D002493:Central Nervous System Diseases / Q000139:chemically induced; D004347:Drug Interactions; D006331:Heart Diseases / Q000139:chemically induced; D006633:Histamine Antagonists / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*; D006634:Histamine H1 Antagonists / Q000276:immunology / Q000627:therapeutic use; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy*; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D006633:Histamine Antagonists; D006634:Histamine H1 Antagonists